Table 3 Correlation with the outcome
From: The annual conference of National Cancer Institute - Cairo University "Bridging Gaps in Oncology"
laboratory and imaging investigations | Mortality n (%) | Ventilator n (%) | ICU admission, n (%) | inotropic support, n (%) | |
|---|---|---|---|---|---|
Possible fungal chest infection | no | 8 (57.1) | 7 (58.3) | 17 (63.0) | 9 (56.3) |
yes | 6 (42.9) | 5 (41.7) | 10 (37.0) | 7 (43.8) | |
CT chest | GGO | 5 (35.7) | 4 (33.3) | 9 (33.3) | 4 (25.0) |
GGO, consolidation | 2 (14.3) | 2 (16.7) | 4 (14.8) | 3 (18.8) | |
consolidation | 1 (7.1) | 1 (8.3) | 4 (14.8) | 3 (18.8) | |
GGO, nodules | 2 (14.3) | 2 (16.7) | 3 (11.1) | 2 (12.5) | |
GGO, consolidation, nodules | 1 (7.1) | 0 (0.0) | 2 (7.4) | 1 (6.3) | |
GGO, nodules, cavitation | 3 (21.4) | 3 (25.0) | 5 (18.5) | 3 (18.8) | |
Degree of chest affection | Mild (4) | 0 (0.0) | 0 (0.0) | 3 (11.1) | 1 (6.3) |
Moderate (32) | 3 (21.4) | 2 (16.7) | 14 (51.9) | 6 (37.5) | |
Sever (13) | 11 (78.6)** | 10(83.3)** | 10 (37.0) | 9(56.3)** | |
Follow-up CT chest | Regressive (15) | 1 (7.1) | 0(0.0) | 6 (22.2) | 2 (12.5) |
Stationary (12) | 0 (0.0) | 0(0.0) | 5 (18.5) | 2 (12.5) | |
ARDS (2) | 1 (7.1) | 1(8.3) | 1 (3.7) | 1 (6.3) | |
Progressive (2) | 2 (14.3)** | 2(16.7)** | 2 (7.4) | 2 (12.5)* | |
NA (17) | 10 (71.4) | 9 (75) | 13 (48.1) | 9 (56.3) | |
Second COVID PCR | Negative (7) | 1 (7.1) | 1 (8.3) | 4 (14.8) | 2 (12.5) |
Positive (30) | 6 (42.9)* | 5 (41.7)* | 16 (59.3) | 9 (56.3) | |
NA (12) | 7 (50.0) | 6 (50.0) | 7 (25.9) | 5 (31.3) | |
Liver functions (billirubin) | Normal (28) | 3 (21.4) | 3 (25.0) | 14 (51.9) | 5 (31.3) |
High (21) | 11 (78.6)** | 9 (75.0)* | 13 (48.1) | 11(68.8)* | |
Cultures | Blood (25) | 6 (42.9) | 5 (41.7) | 9 (33.3) | 8 (50.0) |
Wound (6) | 2 (14.3) | 2 (16.7) | 6 (22.2)** | 2 (12.5%) | |
No (18) | 6 (42.9) | 5 (41.7) | 12 (44.4) | 6 (37.5) | |
CRP>100 | No (7) | 2 (16.7) | 2 (18.2) | 3 (11.5) | 1 (6.7) |
Yes (40) | 10 (83.3) | 9 (81.8) | 23 (88.5) | 14 (93.3) | |
Second CRP | No (10) | 0 (0.0) | 0 (0.0) | 6 (25.0) | 1 (7.7) |
Yes (31) | 11 (100)* | 10 (100) | 18 (75.0) | 12 (92.3) | |
lymphopenia | <400 | 8 (57.1) | 7 (58.3) | 12 (44.4) | 9 (56.3) |
>400 | 6 (42.9) | 5 (41.7) | 15 (55.6) | 7 (43.8) | |
HB (g/dl) | 9 (6-11) | 8.5 (6-10)** | 10 (6-13) | 9 (6-13) | |
TLC (103/Cmm) | 6.5(.2-4000) | 6.5(.2-4000) | 7(.2-4000) | 4(.2-4000) | |
Neutrophil count | 1250(0-21000) | 1250(0-21000) | 600(0-21000) | 1250(0-20000) | |
Lymphocyte count (at diagnosis) | 350(39-2200) | 350(39-2200) | 700(39-3200) | 350(39-3000) | |
Lymphocyte count (follow up) | 455(90-1800) | 420(90-1800) | 1000(0-3000) | 490(90-3200) | |
Platelets (103/Cmm) | 84.5(19-500) | 84.5(19-500) | 100(18-900) | 89.5(19-900) | |
Ferritin (ng/L) | 2900(1000-10000)* | 2950(1000-10000)* | 2000(900-10000) | 2200(1000-10000) | |
LDH (U/L) | 900(0-3000) | 900(0-3000) | 895(0-3000) | 890(0-3000) | |
D dimer (ng/ml) | 1.2(.9-1.3)* | 1.2(.9-1.3) | 1 (.9-1.3) | 1.15(.9-1.3) | |
ALT (U/L) | 200(10-840) | 123(10-840) | 70(10-840) | 125(20-840) | |
AST (U/L) | 111.5 (19-1000) | 95(19-350) | 90(14-500) | 111.5(19-500) | |
Creatinine (mg/dl) | 1.4(.6-2.9)** | 1.35(.6-2.9)* | 1.3(0-3.5)** | 1.35(0-2.9)* | |